Re: cumulative AUC

From: Rob ter Heine Date: November 08, 2019 technical Source: mail-archive.com
Hi Sam, You can activate a flag from 0 to 1 from a certain timepoint (eg FLA1) and integrate the auc as follows Datdt(x)=C*FLA1 Rob Op 8 nov. 2019 om 19:16 heeft Sam Liao <[email protected]> het volgende geschreven:  Dear nmusers, I have a question how to reset cumulative AUC in a $DES model, where DADT(4) is set up as cumulative AUC of C1. Because the study is a four way crossover study, the cumulative value of A(4) need to rest to zero before each subsequent treatments. However, NONMEM do not allow setting A(4) to zero in the statement of control stream. Is there any work around of this problem? Best regards, Sam Liao
Quoted reply history
On 11/7/2019 7:17 AM, Farrell, Colm wrote: At ICON, it’s our people that set us apart. As a global provider of drug development solutions, our work is serious business. But that doesn’t mean you can’t have fun while you do it. With our vision to be the partner of choice in drug development, we hire only the best and brightest in the industry. Are you one of them? Due to the continuing demand to support our clients in drug development through the integration of modelling and simulation into clinical development programs, ICON is looking for an experienced pharmacometrician to join our global PKPDM&S team, with a key responsibility to develop and apply M&S strategies, study designs and analyses across all phases of drug development. With members of the PKPDM&S based in UK and USA, we’re flexible on the location. The role · Prepare PKPDM&S-based strategies to support clinical development programs; · Design, conduct, interpret and prepare appropriate study and regulatory summaries of PKPDM&S activities; · Build and sustain great relationships with clients; · Prepare and present scientific publications; · Serve as scientific reviewer and staff mentor to colleagues. What you need · PhD (or equivalent experience) in pharmacokinetics/PKPD with proven industry or academic post PhD experience; · Excellent understanding of the integration of PKPDM&S into clinical drug development · Demonstrated expertise in hands-on population-based modelling e.g. NONMEM, Monolix and related software (R, Xpose, PsN); · Proven mentorship capabilities. Why join us ICON enjoys a strong reputation for quality and is focused on staff development. We make it our mission to attract the most diverse and creative minds into the business and we continually strive to provide opportunities for our people to excel, grow and build a phenomenal career. We understand that our greatest asset is the skills and talents of our people and they are truly what set us apart. Other than working with a great team of switched on and ambitious people, we also offer a very competitive benefits package. This varies from country to country so a dedicated recruiter will discuss this with you at interview stage. We care about our people as they are the key to our success. We provide an open and friendly work environment where we empower people and provide them with opportunities to develop their long term career. ICON is an equal opportunity employer - M/F/D/V and committed to providing a workplace free of any discrimination or harassment. To find out more and apply for the role, please visit: https://icon.wd3.myworkdayjobs.com/broadbean_external/job/UK-London-Marlow/Senior-PK-Scientist-II_061382-1
Nov 08, 2019 Sam Liao cumulative AUC
Nov 08, 2019 Rob ter Heine Re: cumulative AUC
Nov 08, 2019 Rob ter Heine Re: cumulative AUC
Nov 08, 2019 Leonid Gibiansky Re: cumulative AUC
Nov 08, 2019 Ruben Faelens Re: cumulative AUC
Nov 08, 2019 Matt Fidler Re: cumulative AUC
Nov 20, 2019 Dongfen Yuan RE: cumulative AUC